Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
So-Young International Inc (SY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: SY (4-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $5.8
1 Year Target Price $5.8
| 1 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 50.84% | Avg. Invested days 32 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 09/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 374.44M USD | Price to earnings Ratio - | 1Y Target Price 5.8 |
Price to earnings Ratio - | 1Y Target Price 5.8 | ||
Volume (30-day avg) 2 | Beta 1.91 | 52 Weeks Range 0.64 - 6.28 | Updated Date 09/15/2025 |
52 Weeks Range 0.64 - 6.28 | Updated Date 09/15/2025 | ||
Dividends yield (FY) 5.26% | Basic EPS (TTM) -0.93 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -46.32% | Operating Margin (TTM) -12.44% |
Management Effectiveness
Return on Assets (TTM) -3.08% | Return on Equity (TTM) -29.74% |
Valuation
Trailing PE - | Forward PE 16.05 | Enterprise Value 283146578 | Price to Sales(TTM) 0.26 |
Enterprise Value 283146578 | Price to Sales(TTM) 0.26 | ||
Enterprise Value to Revenue 1.42 | Enterprise Value to EBITDA 2.3 | Shares Outstanding 83721200 | Shares Floating 37042600 |
Shares Outstanding 83721200 | Shares Floating 37042600 | ||
Percent Insiders 1.13 | Percent Institutions 24.49 |
Upturn AI SWOT
So-Young International Inc
Company Overview
History and Background
So-Young International Inc., founded in 2013, operates an online platform in China connecting consumers with healthcare service providers, primarily focusing on medical aesthetics. It has grown from a content-sharing platform to a comprehensive service provider.
Core Business Areas
- Information Services: Provides user-generated content, professional content, and social networking features related to medical aesthetics.
- Reservation Services: Facilitates reservations and appointments for medical aesthetic treatments.
- Other Services: Includes e-commerce and other related services, such as insurance and financing.
Leadership and Structure
The leadership team consists of Jin Xing (CEO), and the organizational structure is based on functional departments overseeing different aspects of the platform and its services.
Top Products and Market Share
Key Offerings
- So-Young Platform: A comprehensive platform for medical aesthetics, including articles, reviews, and booking services. Revenue is heavily reliant on this platform. Competition includes Meituan and Alibaba Health.
- Reservation Services: Facilitates appointment bookings and treatment reservations. Exact market share is difficult to pinpoint, but the company is a significant player. Competition includes local clinics that have their own private reservation systems.
Market Dynamics
Industry Overview
The medical aesthetics industry in China is experiencing rapid growth, driven by increasing disposable incomes and a rising demand for cosmetic procedures.
Positioning
So-Young International Inc is a leading player in the online medical aesthetics market in China, providing a platform for information sharing and reservation services. Its competitive advantage lies in its established user base and extensive content.
Total Addressable Market (TAM)
The TAM for medical aesthetics in China is estimated to be in the billions of dollars annually. So-Young is positioned to capture a significant share through its online platform, but faces competition and regulatory challenges.
Upturn SWOT Analysis
Strengths
- Large user base
- Extensive content library
- Established brand recognition
- Strong online presence
- High-quality user-generated content
Weaknesses
- Heavy reliance on user-generated content
- Exposure to regulatory risks in China
- Competition from larger internet platforms
- Susceptibility to negative publicity and fake reviews
- Revenue concentration in a few major cities
Opportunities
- Expansion into new geographic markets within China
- Development of new services and products
- Partnerships with medical institutions
- Increased adoption of online medical aesthetics platforms
- Growth of the aging population in China
Threats
- Increased competition from existing and new players
- Changes in government regulations
- Economic slowdown in China
- Negative publicity and fake reviews
- Data security and privacy concerns
Competitors and Market Share
Key Competitors
- Meituan (OTCPK:MPNGY)
- Alibaba Health (OTCPK:ALBHF)
Competitive Landscape
So-Young's niche focus provides expertise. However, it needs to compete with bigger, more-established competitors and their larger user base.
Growth Trajectory and Initiatives
Historical Growth: Past growth based on the growth of the China medical aesthetics market, but recent financial struggles have impacted growth.
Future Projections: Future growth dependent on market conditions and regulatory environment. Analyst estimates vary. Check with financial institutions for future projections.
Recent Initiatives: Initiatives to improve content quality, user experience, and compliance with regulations are key.
Summary
So-Young International Inc. is a prominent player in China's online medical aesthetics market, leveraging user-generated content. It faces strong competition from larger platforms and regulatory challenges. The company needs to navigate evolving regulations, maintain content quality, and explore new growth opportunities to sustain its position. While it has a strong niche focus, the need to compete with larger competitors is a constant pressure.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
- Third-party market research reports
- Financial News Outlets
Disclaimers:
The information provided is for informational purposes only and should not be considered as investment advice. Investment decisions should be made after conducting thorough research and consulting with a financial advisor. Market data is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About So-Young International Inc
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2019-05-02 | Co-Founder, CEO & Chairman Mr. Xing Jin | ||
Sector Healthcare | Industry Health Information Services | Full time employees 1800 | Website https://www.soyoung.com |
Full time employees 1800 | Website https://www.soyoung.com | ||
So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users access to medical aesthetic knowledge, community support and reservation options for treatment with medical professionals, and medical aesthetic institutions; Weixin mini program to explore treatment options, check prices, schedule appointments, participate in online consultations, and track follow-ups; and medical aesthetic community content through its website soyoung.com. Its aesthetic centers offer non-invasive and minimally invasive procedures, including device-based options, such as thread lifts, intense pulsed light, ultrasound facelifts, picosecond lasers, and body contouring treatments, as well as injectable treatments, including skin boosters, hyaluronic acid-based products, botox, and type I and type III collagen. In addition, the company engages in the research and development, production, sale, and distribution of light therapy devices, including excimer laser systems, UV excimer therapy devices, LED and red-light therapy systems, and advanced laser and intense pulsed light technologies; surgical laser devices, including carbon dioxide laser machines, multi-wavelength and semiconductor laser systems, and hydrodynamic-assisted liposuction systems, as well as pneumatic liquid spray devices. Further, it offers injectable products; sales and technical, maintenance, installation, operational training, error reporting, maintenance, and equipment packaging services; consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and content management through beauty diaries, short-form videos, treatment reviews, featured articles, and chat messages. The company was founded in 2013 and is headquartered in Chaoyang, China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.